Biovail Pharmaceuticals, Inc.

6 articles with Biovail Pharmaceuticals, Inc.

• Orchard Therapeutics Announces Appointments of Marc Dunoyer and Charlie Rowland to Board of Directors

  6/7/2018

  Orchard Therapeutics today announced the appointments of Marc Dunoyer and Charlie Rowland to its board of directors as independent directors.

• Valeant Pharmaceuticals International and Biovail Pharmaceuticals, Inc. Announce Valeant's Intention to Declare a Special Dividend to Stockholders Upon Obtaining Shareholder Approval, Financing and Satisfaction of Other Closing Conditions

  9/22/2010

• Biovail Pharmaceuticals, Inc., Santhera Pharmaceuticals AG Strike Parkinson's Drug Deal; Santhera Could Pay up to $184 Million

  8/24/2009

• Biovail Pharmaceuticals, Inc. Cuts Dividend 76 Percent as Profit Shrinks

  5/6/2009

• Biovail Pharmaceuticals, Inc. Launches Ralivia(TM) to Canadian Physicians

  11/1/2007

• Biovail Pharmaceuticals, Inc. To Present At The UBS Warburg Global Specialty Pharmaceuticals Conference

  4/21/2006